‘We know more about disease than health,’ but advances in CV imaging may change that

Even in the COVID-19 era, atherosclerotic CVD remains the leading cause of death worldwide.
One possible reason is: “We know more about disease than health,” Valentin Fuster, MD, PhD, MACC, president of Mount Sinai Heart, physician-in-chief at The Mount Sinai Hospital and the Richard Gorlin, MD/Heart Research Foundation Professor at the Icahn School of Medicine at Mount Sinai, said during the American College of Cardiology New York Cardiovascular Symposium, which he chaired.
That being said, 2022 brought numerous advances in the diagnosis and characterization of atherosclerosis and

Even in the COVID-19 era, atherosclerotic CVD remains the leading cause of death worldwide.
One possible reason is: “We know more about disease than health,” Valentin Fuster, MD, PhD, MACC, president of Mount Sinai Heart, physician-in-chief at The Mount Sinai Hospital and the Richard Gorlin, MD/Heart Research Foundation Professor at the Icahn School of Medicine at Mount Sinai, said during the American College of Cardiology New York Cardiovascular Symposium, which he chaired.
That being said, 2022 brought numerous advances in the diagnosis and characterization of atherosclerosis and